Nutrition and the psychoneuroimmunology of postpartum depression

Nutrition Research Reviews

Volumn 25, Issue 1, 2012, Pages 180-192

  Ellsworth Bowers, E R ^a   Corwin, E J ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Immune system; Inflammation; Micronutrients; Postpartum depression

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIDONIC ACID; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; LINOLENIC ACID; NICOTINAMIDE; OMEGA 3 FATTY ACID; PLACEBO; PYRIDOXINE; RETINOL; RIBOFLAVIN; SELENIUM; THIAMINE; TRACE ELEMENT; TUMOR NECROSIS FACTOR ALPHA; VEGETABLE OIL; VITAMIN B GROUP; VITAMIN D; ZINC;

ANTIDEPRESSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BLOOD SAMPLING; CLINICAL PRACTICE; COMPETITIVE INHIBITION; CORRELATION ANALYSIS; CYANOCOBALAMIN DEFICIENCY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DSM-IV; FATTY ACID BLOOD LEVEL; FOOD INTAKE; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; LACTATION; LINSEED; MAJOR DEPRESSION; MATERNAL NUTRITION; MEDLINE; MONOTHERAPY; NEUROPROTECTION; NUTRITIONAL ASSESSMENT; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; PROTEIN BLOOD LEVEL; PSYCHOPHYSIOLOGY; PUERPERAL DEPRESSION; REVIEW; SCREENING TEST; SIGNAL TRANSDUCTION; SOCIAL SUPPORT; SUICIDAL IDEATION; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; ZINC BLOOD LEVEL;

DEFICIENCY DISEASES; DEPRESSION, POSTPARTUM; DIET; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MICRONUTRIENTS; NUTRITIONAL STATUS; PSYCHONEUROIMMUNOLOGY; SELENIUM; VITAMIN B DEFICIENCY; VITAMIN D DEFICIENCY; ZINC;

EID: 84863681442     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422412000091     Document Type: Review

References (125)

1. Yonkers KA, Vigod S & Ross LE (2011) Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstet Gynecol 117, 961-977.
2. Robertson E, Grace S & Wallington T, et al. (2004) Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry 26, 289-295.
3. Corwin EJ, Johnston N & Pugh L (2008) Symptoms of postpartum depression associated with elevated levels of interleukin-1b during the first month postpartum. Biol Res Nurs 10, 128-133.
4. Groer MW & Morgan K (2007) Immune, health and endocrine characteristics of depressed postpartum mothers. Psychoneuroendocrinology 32, 133-139.
5. Bloch M, Rotenberg N, Koren D, et al. (2006) Risk factors for early postpartum depressive symptoms. Gen Hosp Psychiatry 28, 3-8.
6. Miller AH, Maletic V & Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65, 732-741.
7. Dantzer R, O'Connor JC, Freund GG, et al. (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9, 46-56.
8. Maes M, Ombelet W, De Jongh R, et al. (2001) The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system. J Affect Disord 63, 85-92.
9. Maes M, Lin AH, Ombelet W, et al. (2000) Immune activation in the early puerperium is related to postpartum anxiety and depressive symptoms. Psychoneuroendocrinology 25, 121-137.
10. Browne M, Jacobs M, Lahiff M, et al. (2010) Perineal injury in nulliparous women giving birth at a community hospital: reduced risk in births attended by certified nurse-midwives. J Midwifery Womens Health 55, 243-249.
11. O'Brien J, Lyons T, Monks J, et al. (2010) Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol 176, 1241-1255.
12. Angioli R, Gómez-Marín O, Cantuaria G, et al. (2000) Severe perineal lacerations during vaginal delivery: the University of Miami experience. Am J Obstet Gynecol 182, 1083-1085.
13. Connolly AM & Thorp JM (1999) Childbirth-related perineal trauma: clinical significance and prevention. Clin Obstet Gynecol 42, 820-835.
14. Bodnar LM & Wisner KL (2005) Nutrition and depression: implications for improving mental health among childbearing-aged women. Biol Psychiatry 58, 679-685.
15. Murphy PK, Mueller M, Hulsey TC, et al. (2010) An exploratory study of postpartum depression and vitamin D. J Am Psychiatr Nurses Assoc 16, 170-177.
16. Koletzko B, Lien E, Agostoni C, et al. (2008) The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 36, 5-14.
17. Adkins Y & Kelley DS (2010) Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 21, 781-792.
18. Zhao Y, Joshi-Barve S, Barve S, et al. (2004) Eicosapentaenoic acid prevents LPS-induced TNF-a expression by preventing NF-kB activation. J Am Coll Nutr 23, 71-78.
19. Vecchio AJ, Simmons DM & Malkowski MG (2010) Structural basis of fatty acid substrate binding to cyclooxygenase-2. J Biol Chem 285, 22152-22163.
20. Saravanan P, Davidson NC, Schmidt EB, et al. (2010) Cardiovascular effects of marine omega-3 fatty acids. Lancet 376, 540-550.
21. Gleissman H, Johnsen JI & Kogner P (2010) Omega-3 fatty acids in cancer, the protectors of good and the killers of evil? Exp Cell Res 316, 1365-1373.
22. Pestka JJ (2010) n-3 Polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis. Prostaglandins Leukot Essent Fatty Acids 82, 251-258.
23. Harbige LS (2003) Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 38, 323-341.
24. Liperoti R, Landi F, Fusco O, et al. (2009) Omega-3 polyunsaturated fatty acids and depression: a review of the evidence. Curr Pharm Des 15, 4165-4172.
25. Sontrop J & Campbell MK (2006) Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med 42 4-3.
26. Lespérance F, Frasure-Smith N, St-André E, et al. (2011) The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. J Clin Psychiatry 72, 1054-1062.
27. Rondanelli M, Giacosa A, Opizzi A, et al. (2010) Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial. J Am Coll Nutr 29, 55-64.
28. Nemets H, Nemets B, Apter A, et al. (2006) Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 163, 1098-1100.
29. Su K-P, Huang S-Y, Chiu C-C, et al. (2003) Omega-3 fatty acids in major depressive disorder: a preliminary doubleblind, placebo-controlled trial. Eur Neuropsychopharmacol 13, 267-271.
30. Rogers PJ, Appleton KM, Kessler D, et al. (2008) No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br J Nutr 99, 421-431.
31. Silvers KM, Woolley CC, Hamilton FC, et al. (2005) Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids 72, 211-218.
32. Marangell LB, Martinez JM, Zboyan HA, et al. (2003) A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 160, 996-998.
33. Freeman MP, Hibbeln JR, Wisner KL, et al. (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67, 1954-1967.
34. Lu D-Y, Tsao Y-Y, Leung Y-M, et al. (2010) Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for omega-3 fatty acids. Neuropsychopharmacology 35, 2238-2248.
35. Su K-P (2009) Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'? Neurosignals 17 144-152.
36. Al MD, van Houwelingen AC, Kester AD, et al. (1995) Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br J Nutr 74, 55-68.
37. Holman RT, Johnson SB & Ogburn PL (1991) Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc Natl Acad Sci U S A 88, 4835-4839.
38. Otto SJ, Houwelingen AC, Antal M, et al. (1997) Maternal and neonatal essential fatty acid status in phospholipids: an international comparative study. Eur J Clin Nutr 51, 232-242.
39. Hibbeln JR (2002) Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 69, 15-29.
40. De Vriese SR, Christophe AB & Maes M (2003) Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci 73, 3181-3187.
41. Makrides M, Crowther CA, Gibson RA, et al. (2003) Docosahexaenoic acid and post-partum depression -is there a link? Asia Pac J Clin Nutr 12 Suppl. S37.
42. Otto SJ, de Groot RHM & Hornstra G (2003) Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot Essent Fatty Acids 69, 237-243.
43. Browne JC, Scott KM & Silvers KM (2006) Fish consumption in pregnancy and omega-3 status after birth are not associated with postnatal depression. J Affect Disord 90, 131-139.
44. Miyake Y, Sasaki S, Yokoyama T, et al. (2006) Risk of postpartum depression in relation to dietary fish and fat intake in Japan: the Osaka Maternal and Child Health Study. Psychol Med 36, 1727-1735.
45. Llorente AM, Jensen CL, Voigt RG, et al. (2003) Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol 188, 1348-1353.
46. Doornbos B, van Goor SA, Dijck-Brouwer DAJ, et al. (2009) Supplementation of a low dose of DHA or DHA ' AA does not prevent peripartum depressive symptoms in a small population based sample. Prog Neuropsychopharmacol Biol Psychiatry 33, 49-52.
47. Mattes E, McCarthy S, Gong G, et al. (2009) Maternal mood scores in mid-pregnancy are related to aspects of neonatal immune function. Brain Behav Immun 23, 380-388.
48. Freeman MP, Davis M, Sinha P, et al. (2008) Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. J Affect Disord 110, 142-148.
49. Rees A-M, Austin M-P & Parker GB (2008) Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial. Aust N Z J Psychiatry 42, 199-205.
50. Makrides M, Gibson RA, McPhee AJ, et al. (2010) Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial. JAMA 304 1675-1683.
51. Su K-P, Huang S-Y, Chiu T-H, et al. (2008) Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 69, 644-651.
52. Freeman MP, Hibbeln JR, Wisner KL, et al. (2006) Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 113, 31-35
53. Jans LAW, Giltay EJ & Van der Does AJW (2010) The efficacy of n-3 fatty acids DHA and EPA (fish oil) for perinatal depression. Br J Nutr 104, 1577-1585.
54. Smulders YM & Blom HJ (2011) The homocysteine controversy. J Inherit Metab Dis 34, 93-99.
55. Beydoun MA, Shroff MR, Beydoun HA, et al. (2010) Serum folate, vitamin B-12, and homocysteine and their association with depressive symptoms among U.S. adults. Psychosom Med 72, 862-873.
56. Malouf R & Grimley Evans J (2003) The effect of vitamin B6 on cognition. The Cochrane Database of Systematic Reviews 2003, issue 4, CD004393. . wiley.com/cochrane/clsysrev/articles/CD004393/frame.html
57. Robinson D, O'Luanaigh C, Tehee E, et al. (2011) Associations between holotranscobalamin, vitamin B12, homocysteine and depressive symptoms in community-dwelling elders. Intl J Geriatr Psychiatry 26, 307-313.
58. Skarupski KA, Tangney C, Li H, et al. (2010) Longitudinal association of vitamin B-6, folate, and vitamin B-12 with depressive symptoms among older adults over time. Am J Clin Nutr 92, 330-335.
59. Tiemeier H, van Tuijl HR, Hofman A, et al. (2002) Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry 159, 2099-2101.
60. Murakami K, Miyake Y, Sasaki S, et al. (2010) Dietary folate, riboflavin, vitamin B-6, and vitamin B-12 and depressive symptoms in early adolescence: the Ryukyus Child Health Study. Psychosom Med 72, 763-768.
61. Almeida OP, Marsh K, Alfonso H, et al. (2010) B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial. Ann Neurol 68, 503-510.
62. Fava M & Mischoulon D (2009) Folate in depression: efficacy, safety, differences in formulations, and clinical issues. J Clin Psychiatry 70, Suppl. 5, 12-17.
63. Ford AH, Flicker L, Thomas J, et al. (2008) Vitamins B12, B6,and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial. J Clin Psychiatry 69, 1203-1209.
64. Miyake Y, Sasaki S, Tanaka K, et al. (2006) Dietary folate and vitamins B12, B6, and B2 intake and the risk of postpartum depression in Japan: the Osaka Maternal and Child Health Study. J Affect Disord 96, 133-138.
65. Rouillon F, Thalassinos M, Miller HD, et al. (1992) Folates and post partum depression. J Affect Disord 25, 235-241.
66. Kesby JP, Eyles DW, Burne THJ, et al. (2011) The effects of vitamin D on brain development and adult brain function. Mol Cell Endocrinol 347, 121-127.
67. Borges MC, Martini LA & Rogero MM (2011) Current perspectives on vitamin D, immune system, and chronic diseases. Nutrition 27, 399-404.
68. Garcion E, Wion-Barbot N, Montero-Menei CN, et al. (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13, 100-105.
69. Obradovic D, Gronemeyer H, Lutz B, et al. (2006) Crosstalk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem 96, 500-509.
70. Lee DM, Tajar A, O'Neill TW, et al. (2011) Lower vitamin D levels are associated with depression among communitydwelling European men. J Psychopharmacol 25, 1320-1328.
71. Hoogendijk WJG, Lips P, Dik MG, et al. (2008) Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 65, 508-512.
72. Jorde R, Waterloo K, Saleh F, et al. (2006) Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study. J Neurol 253, 464-470.
73. Pan A, Lu L, Franco OH, et al. (2009) Association between depressive symptoms and 25-hydroxyvitamin D in middleaged and elderly Chinese. J Affect Disord 118, 240-243.
74. Eskandari F, Martinez PE, Torvik S, et al. (2007) Low bone mass in premenopausal women with depression. Arch Intern Med 167, 2329-2336.
75. Wilkins CH, Sheline YI, Roe CM, et al. (2006) Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 14, 1032-1040.
76. Schneider B, Weber B, Frensch A, et al. (2000) Vitamin D in schizophrenia, major depression and alcoholism. J Neural Transm 107, 839-842.
77. Herrán A, Amado JA, García-Unzueta MT, et al. (2000) Increased bone remodeling in first-episode major depressive disorder. Psychosom Med 62, 779-782.
78. Michelson D, Stratakis C, Hill L, et al. (1996) Bone mineral density in women with depression. N Engl J Med 335, 1176-1181.
79. Jorde R, Sneve M, Figenschau Y, et al. (2008) Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 264, 599-609.
80. Sanders KM, Stuart AL, Williamson EJ, et al. (2011) Annual high-dose vitamin D3 and mental well-being: randomized controlled trial. Br J Psychiatry 198, 357-364.
81. Parker G & Brotchie H (2011) 'D' for depression: any role for vitamin D? 'Food for Thought' II. Acta Psychiatr Scand 124, 243-249.
82. Bertone-Johnson ER (2009) Vitamin D and the occurrence of depression: causal association or circumstantial evidence? Nutr Rev 67, 481-492.
83. Fairweather-Tait SJ, Bao Y, Broadley MR, et al. (2011) Selenium in human health and disease. Antioxid Redox Signal 14, 1337-1383.
84. Maret W & Sandstead HH (2006) Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 20, 3-18.
85. Prasad AS (2009) Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 12, 646-652.
86. Ibs K-H & Rink L (2003) Zinc-altered immune function. J Nutr 133, 1452S-1456S.
87. Prasad AS, Beck FWJ, Bao B, et al. (2008) Duration and severity of symptoms and levels of plasma interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate. J Infect Dis 197, 795-802.
88. Beck FW, Prasad AS, Kaplan J, et al. (1997) Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol 272, E1002-E1007.
89. Fraker PJ & King LE (2004) Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr 24, 277-298.
90. Duntas LH (2009) Selenium and inflammation: underlying anti-inflammatory mechanisms. Horm Metab Res 41, 443-447.
91. Kiremidjian-Schumacher L, Roy M, Wishe HI, et al. (1994) Supplementation with selenium and human immune cell functions: effect on cytotoxic lymphocytes and natural killer cells. Biol Trace Elem Res 41, 115-127.
92. Hoffmann PR & Berry MJ (2008) The influence of selenium on immune responses. Mol Nutr Food Res 52, 1273-1280.
93. Broome CS, McArdle F, Kyle JAM, et al. (2004) An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am J Clin Nutr 80, 154-162.
94. Raucci R, Colonna G, Guerriero E, et al. (2011) Structural and functional studies of the human selenium binding protein-1 and its involvement in hepatocellular carcinoma. Biochim Biophys Acta 1814, 513-522.
95. Sanmartín C, Plano D, Font M, et al. (2011) Kinase regulation by sulfur and selenium containing compounds. Curr Cancer Drug Targets 11, 496-523.
96. Yang H, Fang J, Jia X, et al. (2011) Chemopreventive effects of early-stage and late-stage supplementation of vitamine and selenium on esophageal carcinogenesis in rats maintained on a low vitamin E/selenium diet. Carcinogenesis 32, 381-388.
97. Brozmanová J, Mániková D, Vlčková V, et al. (2010) Selenium: a double-edged sword for defense and offence in cancer. Arch Toxicol 84, 919-938.
98. Jensen JD, Wing GJ & Dellavalle RP (2010) Nutrition and melanoma prevention. Clin Dermatol 28, 644-649.
99. Sawada T & Yokoi K (2010) Effect of zinc supplementation on mood states in young women: a pilot study. Eur J Clin Nutr 64, 331-333.
100. Maes M, D'Haese PC, Scharpé S, et al. (1994) Hypozincemia in depression. J Affect Disord 31, 135-140.
101. Marcellini F, Giuli C, Papa R, et al. (2006) Zinc status, psychological and nutritional assessment in old people recruited in five European countries: Zincage study. Biogerontology 7, 339-345.
102. DiGirolamo AM & Ramirez-Zea M (2009) Role of zinc in maternal and child mental health. Am J Clin Nutr 89, 940S-945S.
103. Nowak G, Siwek M, Dudek D, et al. (2003) Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol 55, 1143-1147.
104. Szewczyk B, Poleszak E, Sowa-Kućma M, et al. (2008) Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep 60, 588-589.
105. Tae WS, Kim SS, Lee KU, et al. (2011) Hippocampal shape deformation in female patients with unremitting major depressive disorder. Am J Neuroradiol 32, 671-676.
106. Benton D & Cook R (1991) The impact of selenium supplementation on mood. Biol Psychiatry 29, 1092-1098.
107. Hawkes WC & Hornbostel L (1996) Effects of dietary selenium on mood in healthy men living in a metabolic research unit. Biol Psychiatry 39, 121-128.
108. Finley J & Penland J (1998) Adequacy or deprivation of dietary selenium in healthy men. J Trace Elem Exp Med 11, 11-27.
109. Rayman M, Thompson A, Warren-Perry M, et al. (2006) Impact of selenium on mood and quality of life: a randomized,controlled trial. Biol Psychiatry 59, 147-154.
110. Sher L (2001) Role of thyroid hormones in the effects of selenium on mood, behavior, and cognitive function. Med Hypotheses 57, 480-483.
111. Castaño A, Ayala A, Rodríguez-Gómez JA, et al. (1997) Low selenium diet increases the dopamine turnover in prefrontal cortex of the rat. Neurochem Int 30, 549-555.
112. Wójcik J, Dudek D, Schlegel-Zawadzka M, et al. (2006) Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels. Pharmacol Rep 58, 571-576.
113. Maes M, Vandoolaeghe E, Neels H, et al. (1997) Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 42, 349-358.
114. Mokhber N, Namjoo M, Tara F, et al. (2011) Effect of supplementation with selenium on postpartum depression: A randomized double-blind placebo-controlled trial. J Matern Fetal Neonatal Med 24 104-108.
115. Cheatham CL, Nerhammer AS, Asserhøj M, et al. (2011) Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids 46, 637-645.
116. Duncan A, Talwar D, McMillan DC, et al. (2012) Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. Am J Clin Nutr 95, 64-71.
117. Lucas M, Asselin G, Mérette C, et al. (2009) Validation of an FFQ for evaluation of EPA and DHA intake. Public Health Nutr 12, 1783-1790.
118. Andersen LF, Solvoll K & Drevon CA (1996) Very-long-chain n-3 fatty acids as biomarkers for intake of fish and n-3 fatty acid concentrates. Am J Clin Nutr 64, 305-311.
119. Cox JL, Holden JM & Sagovsky R (1987) Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150, 782-786.
120. Beck CT & Gable RK (2000) Postpartum Depression Screening Scale: development and psychometric testing. Nurs Res 49, 272-282.
121. Strøm M, Mortensen EL, Halldorsson TI, et al. (2009) Fish and long-chain n-3 polyunsaturated fatty acid intakes during pregnancy and risk of postpartum depression: a prospective study based on a large national birth cohort. Am J Clin Nutr 90, 149-155.
122. Freeman MP (2009) Omega-3 fatty acids in major depressive disorder. J Clin Psychiatry 70, Suppl. 5, 7-11.
123. Kendall-Tackett K (2010) Long-chain omega-3 fatty acids and women's mental health in the perinatal period and beyond. J Midwifery Womens Health 55, 561-567.
124. Leung BMY & Kaplan BJ (2009) Perinatal depression: prevalence, risks, and the nutrition link -a review of the literature. J Am Diet Assoc 109, 1566-1575.
125. Turner KM, Sharp D, Folkes L, et al. (2008) Women's views and experiences of antidepressants as a treatment for postnatal depression: a qualitative study. Fam Pract 25, 450-455.